UroGen Pharma (NASDAQ:URGN) reported its Q1 earnings results on Thursday, May 11, 2023 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

UroGen Pharma beat estimated earnings by 2.26%, reporting an EPS of $-1.3 versus an estimate of $-1.33.

Revenue was up $3.63 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.15 which was followed by a 8.9% drop in the share price the next day.

Here's a look at UroGen Pharma's past performance:

To track all earnings releases for UroGen Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.